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Abstract
Objective: The purpose of this review is to summarize the
findings regarding the prevalence and risk factors of
Diabetes Mellitus in developed and developing world and
to review the management options for Diabetes Mellitus
especially the role of telemedicine.
Methodology: Extensive literature review was carried by
retrieving articles from various databases like Pub med,
Google scholar, Science direct, Scopus and Archives of
Medicine. Relevant articles were retrieved from different
databases by using text words and phrases like ‘Diabetes
Mellitus’, ‘Management’, ‘risk factors’, ‘prevalence of
Diabetes’, ‘telemedicine’, ‘e- health’. Types of studies were
descriptive studies, systematic reviews and various
reports.
Findings: Various supporting systems have been made to
upgrade the management of type 2 Diabetes Mellitus
including mobile phones and internet. Mobile phones and
internet are mechanical support tools for the patients
with type 2 DM to improve their health by facilitating
good communication between the patients and their
respective health care providers.
Conclusion: There are multiple ways of managing
Diabetes Mellitus ranging from oral medicines to insulin.
These can be done either through the visits to the
patients or the patients can be reminded to take the
medicines through telemedicine. Telemedicine can play
an important role in managing the patients with chronic
diseases including Diabetes Mellitus.
Keywords: Diabetes mellitus; Management; Telemedicine
Introduction
Diabetes Mellitus is one of the chronic diseases which can
affect almost all age groups worldwide. Approximately 150
million people have diabetes mellitus worldwide, and this
number may well double by the year 2025. Prevalence of this
disease seems to be increasing and among all the diabetic
cases in the world more than 90% are type 2 DM. Type 2 DM
cannot be cured permanently however various methods are
available worldwide to manage this disease.
Background
Diabetes Mellitus (DM) is a metabolic disorder, diagnosed by
the high level of glucose in the blood. It is possible in two
conditions. Firstly, when the pancreas does not produce
sufficient amount of insulin compared to the requirements of
the body and secondly when the body is unable to properly
utilize the insulin. Uncontrolled DM ends up with high blood
sugar and with the passage of time it causes serious harm to
many parts of the body, especially the nervous and
cardiovascular system [1].
There are two major types of DM, type I and type II. Type I
DM (formerly known as insulin- dependent DM or child onset
DM) is a life-long condition, affecting children, young people
and adults worldwide. Type II DM is a non-insulin dependent
DM, closely linked with sedentary lifestyle and obesity [2]. The
purpose of this review is to summarize the findings regarding
the prevalence and risk factors of Diabetes Mellitus in
developed and developing world and to review the
management options for Diabetes Mellitus especially the role
of telemedicine.
Methodology
An extensive review was carried out by retrieving articles
from various databases like Pub med, Google scholar, Science
direct, Scopus Archives of Medicine and World Bank and WHO
databases. Relevant articles were retrieved from different
databases by using following text words and phrases: ‘Diabetes
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Mellitus’, ‘Management’, ‘risk factors’, ‘prevalence of Diabetes’,
‘telemedicine’, ‘e-health’. Types of studies included were
descriptive studies, observational studies, correlational studies
and comparative studies. In addition to this; different reports
were also being studied including World Health Organization
and World Bank reports. A literature search was completed
within the six months from January 2012 to July 2012 except
for few articles and reports which were also retrieved later on.
The inclusion criteria for the studies was that the studies have
been written in the English language, from 2000 to 2013,
reporting data on the burden of Diabetes Mellitus, risk factors
and management of Diabetes Mellitus.
The review was extensively done by the primary and
secondary author of this study and only those articles were
included in the literature review for which both of the authors
showed agreement.
Prevalence of diabetes mellitus globally
Diabetes Mellitus is one of the chronic diseases which can
affect almost all age groups worldwide. Approximately 150
million people have diabetes mellitus worldwide, and this
number may well double by the year 2025 [3]. By 2025, most
people with diabetes in developed countries will be aged 65
years or more, in developing countries most will be in the
45-64 year age bracket and affected in their most productive
years [3]. Diabetes Mellitus is one of the chronic diseases
which can affect almost all age groups worldwide. Prevalence
of this disease seems to be increasing and among all the
diabetic cases in the world more than 90% are type 2 DM [4,5].
Literature shows that every year approximately 7 million
individuals develop this chronic disease. In 2000, 171 million
people were suffering from DM all over the world [6], this
number has reached to 285 million in 2010. It is anticipated
that this number will rise up to 439 million cases in the next
few years, hence the number of individuals in developing and
developed countries will increase by 69% and 20%,
respectively [7].
Over 80% of DM deaths took place in developing countries.
World Health Organization [WHO] estimates that, DM deaths
might double between 2005 and 2030 [4]. Total number of
deaths attributed to DM in 2010 showed an overall 5.5%
increase as compared to the estimates for the year 2007. This
rise in number of deaths are due to a 29% increase in North
America and Caribbean Region, a 12% in the South East Asia
Region and 11% increase in the Western Pacific Region [8].
Prevalence of diabetes mellitus in developing
world
It has been estimated that, during 2010 and 2030 there
would be 69% and 20% increase in the number of cases of DM
in developing and developed countries as described above,
because in developing countries, early diagnosis of DM is very
unsatisfactory and half of the people with DM are diagnosed
in late stages. Besides this, adequate treatment of the disease
is also a big issue which leads to rise in number of deaths in
developing countries [8]. Compared to other regions of the
world, percentage of people with DM is very high in Asian
countries. It was estimated in 2010 that the regional
prevalence was 7.0%, and it was expected to increase up to
8.4% by 2030 [9].
While doing a comparison with the rest of the world, India
and China were reported to have the highest prevalence of DM
in 2009. In India it was estimated that around 50.8 million
people were suffering with DM and has relatively more
number of people with DM compared to china and Pakistan
[9]. A study was conducted in India, reported that the
prevalence in female individuals was 16.7% and in males it was
9.7% [10]. While in China approximately 43.2 million
individuals were suffering from DM [8].
In 2003 the prevalence of DM in Pakistan was 6.2%, while it
was anticipated at that time that it would increase to 11.6% in
2025 [11]. According to International Diabetic Federation,
overall prevalence in Pakistan was 7.6% in 2010 [12]. Since it is
increasing very rapidly, we can assume that the prevalence
would be much higher than the estimated prevalence in 2010.
A study conducted in 2007 in Pakistan found that glucose
intolerance including DM was 22.04% in urban areas and
17.15% in rural areas [13]. It shows that the people who are
living in the urban area are more prone to DM as compared to
those in a rural area. But overall, in rural and urban areas, both
males and females are suffering from DM, as shown in Table 1.
Table 1 Prevalence and incidence of type 2 Diabetes Mellitus in Pakistan.
Author and Year of
Study
Place of Study Study Size, Sample
Size
Prevalence (%) of Type 2 DM
Male Female Overall
Zafar et al. [15] Rawalpindi Community, 1091 15.41 12.31 13.14
Shera et al. [15] Multan and rural
Mankot areas of
Punjab
Community, 1852 12.41 9.83
Shera et al. [15] All four provinces of
Pakistan
Community, 5433 12.14 9.83
Basit et al. [16] Baluchistan Community, 2032 10.1 4.3 6.3
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Shera et al. [17] Baluchistan [Quetta,
killimengal]
Community, 1404 11.1 10.6 10.8
Shera et al. [17] KPK [Pakistan] Community, 1035 9.2 11.6 11.1
Shera [19] Shikarpur Community, 967 9 6.3
Risk factors of type-2 diabetes mellitus
Risk factors of type 2 DM are mainly divided into two
categories i.e., modifiable and non-modifiable. Modifiable risk
factors included obesity, sedentary lifestyle, high blood
pressure and dietary intake [20]. By controlling these risk
factors development of type 2 DM can be prevented on a large
scale. Non-modifiable risk factors are age, genetics i.e., family
history, which cannot be modified. Among all these risk
factors, most important risk factors are family history, obesity,
lack of exercise and dietary intake, reported by different
studies conducted in different settings including Australia,
Japan and USA [21-23].
The chances of development of type 2 DM is much greater
in the first degree relatives with DM found by a cross-sectional
study recently conducted [in 2012] in Turkey on 125
participants [24]. An another cohort study [mean follow-up of
23.5 years initiated in 1974] conducted in Finland on 18,831
persons (16061 Swedish and 2770 Finnish) found in 2008 that
individuals with a family history of DM and obesity are more
prone to develop type 2 DM as compared to the people who
do not have family members with such history [25].
Obesity is one of the most important independent risk
factors for the development of type 2 DM. A retrospective
cohort study conducted in Japan on 969 males and 585 female
reported that hazard ratio for the development of type 2 DM
among individuals with BMI 25 to 27.4 was 3.12 while for
those whose BMI was 27.5 or greater was 3.80, and concluded
that obesity can independently cause type 2 DM [26]. Obesity
itself may be caused by over eating, inactive lifestyle or
genetics. Fast food [high fat and high sugar food] has been
considered as one of the causes of obesity. A study conducted
in the USA reported that changing dietary pattern i.e.,
reducing high fat intake and increasing fruits and vegetables
can reduce the weight in obese people [27]. Healthy and
nutritious diet should be preferred over fast food to prevent
obesity, which in turn will reduce the chances of development
of type 2 DM [28]. Central obesity is more dangerous and
those who have central obesity are at higher risk of developing
diabetes, which is being caused by fast food and sedentary
lifestyle [29].
Exercise is considered the most efficient behavioral therapy
for type 2 DM prevention and management [30]. Exercise aids
in blood glucose absorption and maintains its level in the body
according to body’s requirement [31,32]. Various clinical trials
demonstrated that the lifestyle interventions reduce the risk of
developing type 2 diabetes [33]. A follow-up study conducted
in UK on 3012 men in 2012 observed that even light physical
activity can prevent the development of diabetes in older age
groups [34].
Diet plays a major role both in the prevention [35] and
management of type 2 DM [36]. Over eating of high calorie
foods like fast food is very dangerous, it can lead to central
obesity as well as various chronic diseases like heart disease
and type 2 DM [37]. Dietary interventions showed a reduction
in the development of diabetes found by a review study
conducted [in 2012] in Harokopio University [Dept. of
Nutrition and dietetics] Greece, on the role of diet in
prevention and management of type 2 DM [38]. Another study
was conducted in Massachusetts, the USA on 312 participants
found that lifestyle intervention especially diet plays a major
role in the risk reduction of type 2 DM by reducing weight and
caloric percentage from total and saturated fat [39].
Similar to other countries the risk of developing type 2 DM
in Pakistani population is very high. Risk factors of diabetes are
increasing in Pakistan like other countries in spite of having
awareness. [40]. Major risk factors of type 2 DM in Pakistani
population are obesity, family history, hypertension, and
increased age found by a cross-sectional study conducted in
Rawalpindi in July 2008 on 1091 subjects [14].
Findings of Literature Review
Management of diabetes
Type 2 DM cannot be cured permanently, however, various
methods are available worldwide to manage this disease.
Around the world majority of the diabetic patients are being
treated with physical activity, diet, and medicines (oral
medications and Insulin).
Management by using Insulin and oral
medicines
Insulin is prescribed for patients with uncontrolled type 2
DM because it is difficult to manage with oral medication and
behavioral modification in such patients. Oral medication can
only control the disease in moderate situations. But there are
several side-effects reported with the oral hypoglycemic
medicines and Insulin. Troglitazone is an oral drug which can
cause liver toxicity [41] and Acarbose is responsible for
flatulence and diarrhea [42]. Various studies provide evidence
that treating patients with Insulin increases the weight of the
patients [43,44], which can be an adverse effect on the
prognosis of the disease. But it has been proven that the
combined treatment of type 2 DM i.e., physical activity and
dietary counseling with medication is more beneficial [45].
Medications are always prescribed with dietary guidelines and
counseling because patients will not be able to control the
disease alone with medicines without compliance to dietary
guidelines especially recommended for DM.
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Management by physical activity
Evidence also shows that physical activity plays a major role
in both prevention and prognosis of the majority of chronic
diseases including type 2 DM [46]. Physical activity includes
brisk walking, exercise, jogging and any type of activity which
keeps an individual physically active and healthy. It helps in the
regulation of glucose in the body. Various studies reported that
routine exercise can improve the HbA1c in diabetic patients
[47,48], which is an indication of control of blood glucose in
the past three months. For diabetic patients, daily physical
activity is recommended for homeostasis of glucose level. A
systematic review study was conducted in 2001 on the
effectiveness of self-management training in type 2 diabetes,
found that out of total 84 articles 72 articles gave positive
results on the effectiveness of behavioral interventions
including physical activity and diet in reducing the blood
glucose level in the diabetic patients [49].
Management by diet
Especially in the case of type 2 DM, blood glucose and body
weight of diabetic patients can be controlled by taking care of
diet [50], however, more counseling and motivation is a need
for its effectiveness [51]. Diet can deteriorate as well as help in
the prognosis of the disease, but it depends on how much a
diabetic patient understands about the dietary management.
Weight loss by controlling dietary intake in diabetic patients
can improve DM by lowering the blood glucose in the body
[52]. Lower glucose can reduce the complications of type 2
DM, which can be maintained with the help of dietary
guidelines and proper monitoring [53]. Among diabetic
patients dietary compliance is a big issue therefore dietary
guidelines should be very clear and well organized, in order to
make the patients understand and adhere to them [54].
Dietary compliance on regular basis can improve the diabetic
conditions of diabetic patients. Without dietary compliance a
patient cannot control his or her blood glucose with only
medication and [55] and physical activity.
Role of Tele-Health in Disease
Management
Telemedicine
The definition of telemedicine is the use of
telecommunications to support health care. Telemedicine
includes timely transmission and remote interpretation of
patient data for follow up and preventative interventions [56].
By the use of various forms of information technology like the
internet, mobile phone calls, text messages [short message
service] and television programs the provision of treatment
can be made more effective. The key purpose of telemedicine
is to strengthen the communication between patients and the
health care provider which may lead to the improvement of
patient's health and minimizes the cost of the treatment.
Mediums which are being used to distribute the health care
are mobile phones, digital diaries, laptop computers and
clinical decision support systems [CDSS] [57]. To make the
information or the intervention more effective, counseling
material can be distributed through phone calls, text messages
[short message services], e-mails and online video
conversations over the internet [58].
Telemedicine in developed countries
Telemedicine improves the quality of health care delivery in
the developed countries. Developed countries such as USA,
UK, Sweden, Australia, New Zealand, France, Switzerland etc.,
have adopted telemedicine in the health care settings to
minimize the cost of the health care [59,60]. They developed
advance networks of electronic health and telemedicine in
their rural areas so that the people could easily access health
care, which minimize the cost of travel to large cities.
Telemedicine is being used more efficiently in USA [61], UK
[62,63], Australia and New Zeeland [64,65].
It’s more challenging to deliver health care all over the
world in 21st century. Majority of the electronic health and
telemedicine services provided in the developed countries are
based on the diagnosis and clinical management of the chronic
diseases, especially in United Kingdom, Scandinavia, Australia
and North America [66-68]. Measuring and monitoring devices
for heart rate, blood pressure and level of glucose in the body
are also used to remotely manage the patients at distant
places at homes [69], especially in those areas where people
can't easily access health care services. However certain issues
are being faced by the developed counties in provision of
health care through telemedicine and its implementation.
Major issues include breach in patient privacy and
confidentiality, competition in various priorities of health
system and perceived lack of demand [70].
Telemedicine in developing countries
Work is going on feasibility and cost effectiveness of
telemedicine in most of the developing countries like China,
India, Pakistan, Bangladesh, Cambodia and Africa etc. [71,72].
Health care provision is very difficult and is more expensive for
individuals living in rural settings, hence telemedicine can
improve the health status of individuals living in rural areas of
the developing countries [73]. Various strategies are being
studied in many parts of the developing world, like prototype
systems to transfer the results of the bioassays digitally to the
expert health care provider [74] and store-and-forward e-mail
consultative support for mobile non-physician health care
workers to deliver the health care [75]. However, high cost,
poor infrastructure and absence of technical expertise are
considered to be major hurdles in implementing telemedicine
in developing countries [70].
In Pakistan, telemedicine was introduced in 1998, since then
it developed rapidly [76]. The majority of the tertiary care
hospitals are situated in big cities like Islamabad, Karachi,
Lahore, Peshawar, Quetta and Multan etc. Individuals living in
the rural areas were facing problems in receiving good health
care. In the recent years because of advancement in the
telemedicine techniques like store and forward and real time
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medicine [77,78] made delivery of health care easy in these
rural settings to some extent. Telemedicine is used in Pakistan
in various fields of health care provision like dermatology [79],
to diagnose the TB cases [80] and antenatal care provision
[81]. A hospital based cross-sectional study was conducted in
Rawalpindi in 2007 on current status of e-health awareness
among health care professionals, reported that majority are
having access to e- health but some are practicing [82].
However, very little work has been done in the field of
telemedicine for prevention and treatment of type 2 DM.
M-health
Mobile health is a wireless health technology is an area of
electronic health which comes under the domain of
telemedicine. This is an evolving method to improve the
communication between the health care provider and the
patient [83]. Throughout the world there has been rising
interest in health sector to utilize mobile phone in health care
setting. Communications with mobile phones are increasing
rapidly with the time both in developed and developing
countries. In 2002 number of mobile phones used in
worldwide exceeded the landline and its use in developing
world increasing at a higher rate, which can be helpful in
exchanging information about health in these settings [84].
Use of mobile phone in health care provision
Enormous use of media and other electronic devices in the
field of health care has shown success in motivating patients
to improve their health behaviors. Examples of such
technologies include television, computers, Internet [85,86]
and mobile phones [87,88]. A study conducted at St. Gabriel's
Hospital in Malawi, where community health workers were
supplied with mobile phone and were fully trained about its
use in the far flung rural areas for different purposes including
patient compliance reporting, physician queries, and
appointment reminders. It was found that total 2,048 hours of
working time was saved, fuel saving was $2,750 and the
capacity of tuberculosis treatment program was doubled, up
to 200 patients [89].
Another study conducted in USA reported that use of
mobile phone is an inexpensive technique to promote health
care provision and its utilization in health care system in
treatment of various diseases like diabetes, asthma, high blood
pressure and chlamydia trachomatis infection [90]. A study
was conducted on mobile phones with camera to see its use
for clinical microscopy and applicability for global health. The
author reported a positive result after designing an instrument
contains camera-enable mobile and microscope eye piece,
which can help in the early diagnosis of different infectious
diseases in those settings where technical equipment’s are not
available [91].
Mobile phone was also used to see the adherence of the
patients with antiretroviral treatment. A randomized control
trial conducted in Kenya in 2010 in three different clinics on
538 participants, reported that those who were being
reminded through mobile text messages showed a greater
adherence to the treatment [92]. Similarly another trial
conducted in Korea on 51 participants to see the effectiveness
of cellular phone and SMS in glucose control and behavioral
modifications in diabetic participant found a significant
decrease in the HbA1c [93].
Use of mobile phone in the management of
diabetes
Research carried out on the use of mobile phones in the
tertiary health care settings in developed countries, especially
in diabetic individuals, proved that it can improve the blood
glucose levels by motivating the patients to adhere to the
treatment [medications] [94].
Mobile phones and internet are mechanical support tools
for the patients with type 2 DM to improve their health by
facilitating good communication between the patients and
expert endocrinologist. Various supporting systems have been
made to upgrade the management of type 2 DM. A
randomized trial on mobile tele-monitoring in diabetic patients
was conducted in UK, reported that it is helpful in the
maintenance of blood pressure and glucose [95]. It helps in
collecting data to improve the intervention action on blood
glucose levels, HbA1c, behavioral change, such as dietary
modification, exercise, medication dosages and number of
emergency visits [58].
A review study was conducted in 2009 [includes published
studies between January 1990 and March 2008] on behavioral
change interventions delivered by mobile telephone short-
message service, showing 33 such studies, out of which 14 met
their inclusion criteria. 4 out of 14 studies reviewed targeted
preventive health behaviors, Ex: smoking cessation (other
studies also reported that use of mobile phone for smoking
cessation is very effective [96]), and 10 focused on clinical care
(Ex: type 2 DM self-management). According to this review,
positive behavior change outcomes were observed in 13 out of
the 14 studies [97].
Various studies have been done on mobile text message to
manage incurable diseases like diabetes, with the help of
behavior modification [98,99]. Studies have proved that by
motivating patients with reminders through text messages can
improve compliance to dietary counseling and improved
conditions of the patients. A randomized control trial
conducted in Netherland on type 2 diabetic patients (207
subjects) to see the improvements in the adherence to
treatment by using Real Time Medication Monitoring and
mobile text message, found it as an effective method [100].
Recently a study was done in USA to assess the feasibility and
acceptance of mobile text message by the diabetic patients
and reported positive response was found and it was
recommended that its use will prove to be beneficial [101].
One another stud on importance of SMS especially in poor
resource setting conducted in India and it was reported that
this technique can be used as an innovative approach to fight
chronic diseases like type 2 DM [102].
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Conclusion
There could be multiple ways of managing Diabetes Mellitus
ranging from oral medicines to insulin. Management of
Diabetes can be done either through the visits to the patients
or the patients can be reminded to manage the chronic
diseases including Diabetes Mellitus. Telemedicine has played
an important role in the management of multiple chronic
diseases. Thus, telemedicine can be used to remind the
patients to improve their compliance to the medicines of
Diabetes Mellitus.
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